SOMERSET, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced its sponsorship and attendance at the PrecisionMed Exhibition and Summit 2023. The event is scheduled to take place from May 23-24, 2023, at the Dubai World Trade Centre, drawing healthcare professionals from across the Middle East and North Africa.
As part of its expansion into the Middle East, CareCloud has achieved a significant milestone by obtaining its Trade Name Certificate from the United Arab Emirates (UAE) Economic Department. It officially registers CareCloud's name with the UAE for its intended business activities, bringing the Company one step closer to acquiring its trade license, which will enable it to operate in the UAE. Anticipated to be received in the following weeks, potentially by June, the trade license represents CareCloud's commitment to establishing a robust presence in the UAE and capitalizing on the region's burgeoning healthcare opportunities.
For more than two decades, CareCloud has revolutionized the way medical practices operate, making it easier for physicians and healthcare providers to focus on patient care. Leveraging the cost-effectiveness of an educated offshore labor market, CareCloud delivers comprehensive technology-enabled solutions to healthcare organizations of all sizes, encompassing a wide range of specialties.
The PrecisionMed Expo provides an exceptional platform for CareCloud to showcase its latest healthcare technology solutions and enhance brand exposure across the Gulf Corporation Council countries. With a reported 81% of visitors actively seeking new products and 88% expressing interest in meeting suppliers, this event presents invaluable opportunities for CareCloud to cultivate partnerships and foster business growth.
Commenting on the significance of participating in the PrecisionMed Expo 2023, CareCloud President and Chief Executive Officer Hadi Chaudhry said, "As we pursue emerging growth opportunities in the Middle East, our participation in this event is a tremendous opportunity for CareCloud. The imminent plan of the UAE government to mandate electronic health record adoption signifies substantial market potential. We have made remarkable progress in establishing our presence in the country, actively pursuing certification and planning an exciting groundbreaking event at the expo.
“With our extensive experience in EHR, professional services, and technology-enabled revenue cycle management spanning over two decades, coupled with our reputable status as a publicly-traded company in the U.S., we are positioned for success in this region. Furthermore, our cultural familiarity with the Middle East and our cost-effective operations make us an attractive partner for this emerging market. We eagerly anticipate sharing updates on our progress and embracing the meaningful opportunities that lie ahead."
CareCloud's cutting-edge technology-enabled revenue cycle management solutions redefine the next generation of healthcare technology solutions. For further information about CareCloud and its transformative solutions, please visit carecloud.com.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of the Covid-19 pandemic on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. In addition, there is uncertainty about the spread of the Covid-19 virus and the impact it may have on the Company’s operations, the demand for the Company’s services, and economic activity in general.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE CareCloud
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
bkorn@carecloud.com
Investor Contact:
Asher Dewhurst
ICR Westwicke
CareCloudIR@westwicke.com
Media Inquiries:
Alexis Feinberg
ICR Westwicke
CareCloudPR@westwicke.com
